Introduction

The term “fulminant type 1 diabetes (FT1DM)” is derived from the characteristic symptoms documented as “an abrupt onset of diabetic symptoms, thirst and weakness, and the point at which symptoms first developed can be easily determined” [1,2,3]. At admission to hospital, such patients usually show normal HbA1 levels and the extent of their hyperglycemia and ketosis is more severe than in acute-onset type 1 diabetes [1,2,3]. Recent pathological analysis demonstrated that the destructive process progresses rapidly through virus-induced innate and adaptive immune processes and specific host immunogenetic backgrounds [1,2,3,4,5,6,7,8,9] in addition to many molecules not highlighted in type 1 diabetes previously [10, 11].

Pathogenic virus

The virus that causes FT1DM is an acutely cytolytic virus that exhibits tropism mainly to islets and occasionally to exocrine acinar cells [12, 13]. It generally assumed that the causative viruses are belongs to the family Picornaviridae: enterovirus (EV), human herpes virus 6, influenza B virus and cytomegalovirus [14]. Immunohistochemical methods (IHC) and in situ hybridization (ISH) are used to detect EV, by staining freshly cut/prepared sections with the commonly used monoclonal antibody 5D8/1 with the optimized condition to obtain specific IHC staining VP1 in the islet cells (Fig. 1a) [15].

Fig. 1
figure 1

Enterovirus infection in fulminant type 1 diabetes (FT1DM). a Enterovirus (EV) envelope protein 1 (VP1, brown, arrows) staining is positive mainly in beta cells in FT1DM. Acinar cells (arrowheads) are also positive for VP1. b In situ hybridization demonstrate EV-RNA (brown dots) in exocrine pancreatic acinar cells in FT1DM. Numerous RNA dots in acinar cells suggest strong tropism of EV to exocrine acinar cells in FT1DM. c Enterovirus VP1 (red) was stained in the duodenal mucosa in a case with FT1DM

In FT1DM, EVs are found to have tropism both to the islets and exocrine acinar cells of the pancreas (Fig. 1a, b) [12, 15]. Interestingly, EV-positive acinar cells are pyknotic and sometimes de-granulated, and are eosinophilic by Hematoxylin–Eosin (HE) staining [12, 15]. EVs also reside on the duodenal mucosa (Fig. 1c) and are assumed to retrogradely spread from duodenal mucosa to the pancreas through pancreatic ducts or through the systemic circulation in FT1DM and acute-onset type 1 diabetes (AT1DM) [15].

Innate immune responses to viral invasion

The most profound feature of innate immunity against EV invasion in FT1DM is expression of the cytoplasmic pattern recognizing receptors, which include MDA5 and RIG-I receptors. Further, their membrane sensors TLR2, TLR4 and TLR9 are reported in FT1DM [13, 16, 17].

In FT1DM, MDA5, a cytoplasmic double stranded RNA sensor, is expressed in all islet cell subtypes, while RIG-I is expressed specifically in beta cells [16]. Downstream signals are the STAT1 and MyD88 pathways, which induce the expression of type I interferons (IFNα, β) and some proinflammatory cytokines and natural killer (NK) cells (Fig. 2a). The expression of type I IFNs induces class I MHC hyper-expression on the surface of beta cells (Fig. 2b). MHC-class I hyper-expression is a hallmark of migratory immune cells including CD8+ T cells and CD68+ macrophages. Dendritic cells (DCs), which connect innate and adaptive immunity, are activated and engulf beta-cell debris in the islets to present antigen to CD8+ T cells in the regional lymph nodes (Fig. 2c) [16, 17].

Fig. 2
figure 2

Presence of natural killer (NK) cells, dendritic cells (DCs), CD8+ T cells and MHC class-I expressing islet cells. a CD56+ natured killer (NK) cells (arrows) to the islet in FT1DM. b MHC class I hyper-expressed islet cells in FT1DM. Merge image with MHC class I glucagon (red) and insulin (blue). Note that hyper-expression of MHC class I is observed in alpha cells as well as beta cells. c CD11C+ dendritic cells (DCs) are infiltrated around and into the islets. d CD8+ T cell (brown) infiltration to the islets and acinar cells (arrowhead)

Adaptive immunity and destructive mechanisms of islet beta cells

The most predominant pathological feature of enterovirus-induced inflammation in the islets and exocrine pancreas is insulitis and exocrine pancreatic inflammation [12, 15]. The frequency of insulitis among islets is 60%, and most islets are infiltrated by CD8+ T cells, CD68+ macrophages and DCs [15] (Fig. 2d). Characteristically, DCs reside mainly around the islets (Fig. 2c). Beta cells expressing caspase 3 showed T-cell mediated cell damage [16]. Destruction of Fas-positive beta cells by Fas ligand-positive cell-mediated mechanisms is also involved [10, 16].

Another interesting finding regarding islet inflammation is the migratory characteristic of effector cells [19]. They extravasate from the vascular wall near the target islets (Fig. 3a–d), and migrate to the interstitial space (rather than the vasculature of the islets) to reach the target islets, suggesting that specific attracting chemokines may influence their trafficking movements to the target. In addition, the peri-islet region is the final destination of migrating immune cells, indicating that peri-insulitis is common in human type 1 diabetes (Fig. 3d). One of the attracting chemokines is C-X-C motif chemokine 10 (CXCL10), which is expressed on endangered beta cells, and specific ligand-bearing cells (CXCR3+ cells) or macrophages are attracted to and accumulate in the islets [12]. Interestingly, CXCL10 was also expressed on EV-positive acinar cells, suggesting that EV-induced adaptive mechanisms involve the exocrine pancreas attracting virus-specific T cells in FT1DM [15]. Detailed mechanisms of accelerated beta cells in FT1DM was reviewed previously [10].

Fig. 3
figure 3

Migration of CD68+ macrophages to target islets through interstitial space of pancreatic exocrine glands. Fibronectin (green) represents the basement membrane surrounding each gland. a Migration of CD68+ macrophages (red) to the target islet beta cells (blue), penetrating the vascular wall (green). b Magnified view of b in a. c Magnified view of c in a. d The CD68+ macrophages reached and surrounded the target islets in FT1DM

Recent mass spectrometry-based proteomic analysis of inflamed islets in FT1DM detected several proteins not highlighted by classical pathological observation [11] (Table 1).

Table 1 Proteins found only in the islets of FT1DM by mass spectrometry

Table 1 includes 38 molecules associated with cell repair, viral replication, anti-viral function, immune cell migration and viral infection. Plastin-2 (LCP1) was highly expressed on CD8+ T cells and CD68+ macrophages that aggressively infiltrated to or around the islets in FT1DM, indicating a sensitive marker of active migration of T cells or macrophages to the islets [11]. Thymidine phosphorylase (TYMP) is expressed in infiltrating MNCs to the islets of FT1DM, which presumably effector cells and the inhibitors of TYMP are potential targets of intervention of beta-cell destruction [11].

Structural alterations of islets

Structural alterations of islets frequently occur at the basement membranes (BMs), extra-cellular matrix (ECM) packing the islets and cell cluster named Acinar-cell cluster Touching Langerhans islets with Thin Interstitial Surrounding (ATLANTIS): the BMs and ECM were sometimes disrupted during islet inflammation (Fig. 4a) [18]. A detailed description of ATLANTIS is beyond the scope of this review. The mechanisms of structural change of islets and ATLANTIS are mainly related to infiltrating mononuclear cell (MNC), especially CD8+ T cells, DCs and CD68+ macrophages [18]. These cells infiltrate into islets by secreting proteases, which enable immune cells to penetrate the barriers (e.g., BMs and ECMs) surrounding the islets, and disrupt the microenvironment maintained by islets and ALANTIS. Another interesting feature of ATLANTIS in inflamed FT1DM is the increased expression of regenerating protein 1 (Reg 1α) in ATLANTIS. Reg 1α is located in ATLANTIS under non-inflammatory conditions. Under inflammatory conditions the cell cluster hyper-expresses Reg 1α, suggesting crucial roles of ATLANTIS to regenerate the islet cells in an inflammatory milieu of FT1DM [18, 19].

Fig. 4
figure 4

Damaged islet basement membrane (red) by immune cell infiltrated into the islets and hyper-expressing Reg 1alpha in the ATLANTIS cell (green), which touch with beta cells (blue). a Basement membranes (red, fibronectin) encapsulating islets and ATLANTIS cells were damaged by infiltrating effector cells. ATLANTIS cells (asterisks), which is touching with beta cells (blue), hyper-express regenerating protein alpha (Reg 1α) (green, asterisks). b Ki-67+ cells (red, arrows) were increased in beta cells representing active regeneration in the islets of FT1DM (18)

Regeneration of beta cells

Beta-cell kinetics at the onset of FT1DM includes an increased number of Ki67+ beta cells as well as non-beta cells (Fig. 4b). We have also reported increased BrdU+ beta cell regeneration in encephalomyocarditis (EMC) virus-induced diabetes in wild-type mice but not in Reg 1α/ mice [19].

Exocrine pancreatic inflammation

Distinct pathological feature of the pancreas with FT1DM is exocrine pancreatic inflammation never reported previously [15]. Enterovirus is the primary cause of exocrine inflammation (Fig. 1b), which is sometimes associated with clinical symptoms of FT1DM including abdominal pain and hyperamylasemia. Most striking features in pancreatic inflammation go through a similar immunological pathway with insulitis. Enterovirus triggers innate immunity followed by adaptive immunity to cell apoptotic death also in exocrine pancreas in FT1DM. CXCL10 is also expressed in the acinar cells accelerating the processes [15]. As a consequence, autoantibodies against amylase α 2A and heat shock protein 10 are reported in FT1DM [20, 21].

Conclusion

FT1DM is mainly caused by acute cytolytic EV infection to the islets and acinar cells. EVs initiate innate immune activation followed by adaptive immune activation. During innate and adaptive immune conditions, beta cells and acinar cells are affected by chemokine and cytokine exposure. It remains unclear whether EVs persistently infect the pancreas with established pathological features or not. Further study on long-standing features in the pancreas of FT1DM is required.